Switch to:
More From Other Websites
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015 Apr 18 2015
Baxter Files New Drug Application for BAX 855 in Japan - Analyst Blog Apr 17 2015
Huge Biotech Index Rebalance Means Massive Buy Orders for These 4 Stocks Apr 17 2015
Baxter Submits Application To Japan's MHLW For Approval Of BAX 855, Extended Half-Life Recombinant... Apr 16 2015
Baxter Submits Application to Japan’s MHLW for Approval of BAX 855, Extended Half-Life Recombinant... Apr 16 2015
Nektar Therapeutics to Present at the 14th Annual Needham Healthcare Conference Apr 13 2015
Nektar Therapeutics to Present at the 14th Annual Needham Healthcare Conference Apr 13 2015
Nektar Gets Movantik Milestone Payment from AstraZeneca - Analyst Blog Apr 06 2015
Nektar Announces Receipt of $100 Million Milestone Payment from AstraZeneca Apr 02 2015
Nektar Announces Receipt of $100 Million Milestone Payment from AstraZeneca Apr 02 2015
MOVANTIK™ (Naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients... Mar 31 2015
MOVANTIK™ (Naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients... Mar 31 2015
AstraZeneca, Daiichi Sankyo to Co-Market Movantik in U.S. - Analyst Blog Mar 20 2015
AstraZeneca And Daiichi Sankyo To Jointly Commercialise MOVANTIK In The US Mar 19 2015
Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Nektar Therapeutics Mar 18 2015
Nektar Therapeutics (NKTR) Stock Tanks Today on Failed Phase III Breast Cancer Treatment Results Mar 18 2015
Biotech Stock Roundup: Amgen & Regeneron Shine at ACC, Nektar Drug Disappoints - Analyst Blog Mar 18 2015
Nektar's Breast Cancer Candidate Fails in BEACON Study - Analyst Blog Mar 18 2015
What We’re Trading Mar 18 2015
Breast cancer drug, key to Nektar growth plans, fails clinical trial Mar 17 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK